BOLD
Price
$1.09
Change
+$0.04 (+3.81%)
Updated
Jun 16 closing price
Capitalization
24.4M
62 days until earnings call
DNLI
Price
$14.62
Change
+$0.07 (+0.48%)
Updated
Jun 16 closing price
Capitalization
2.12B
44 days until earnings call
Interact to see
Advertisement

BOLD vs DNLI

Header iconBOLD vs DNLI Comparison
Open Charts BOLD vs DNLIBanner chart's image
Boundless Bio
Price$1.09
Change+$0.04 (+3.81%)
Volume$104.57K
Capitalization24.4M
Denali Therapeutics
Price$14.62
Change+$0.07 (+0.48%)
Volume$1.19M
Capitalization2.12B
BOLD vs DNLI Comparison Chart in %
Loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLD vs. DNLI commentary
Jun 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and DNLI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 17, 2025
Stock price -- (BOLD: $1.09 vs. DNLI: $14.62)
Brand notoriety: BOLD and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 89% vs. DNLI: 84%
Market capitalization -- BOLD: $24.4M vs. DNLI: $2.12B
BOLD [@Biotechnology] is valued at $24.4M. DNLI’s [@Biotechnology] market capitalization is $2.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLD is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 3 TA indicator(s) are bullish while DNLI’s TA Score has 5 bullish TA indicator(s).

  • BOLD’s TA Score: 3 bullish, 6 bearish.
  • DNLI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than BOLD.

Price Growth

BOLD (@Biotechnology) experienced а -0.91% price change this week, while DNLI (@Biotechnology) price change was -0.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.54%. For the same industry, the average monthly price growth was +9.91%, and the average quarterly price growth was +7.82%.

Reported Earning Dates

BOLD is expected to report earnings on Aug 18, 2025.

DNLI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-2.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.12B) has a higher market cap than BOLD($24.4M). DNLI YTD gains are higher at: -28.263 vs. BOLD (-62.414). BOLD has higher annual earnings (EBITDA): -72.59M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. BOLD (138M). BOLD (48.6M) and DNLI (48.6M) have identical debt. BOLD (0) and DNLI (0) have equivalent revenues.
BOLDDNLIBOLD / DNLI
Capitalization24.4M2.12B1%
EBITDA-72.59M-505.16M14%
Gain YTD-62.414-28.263221%
P/E Ratio0.14N/A-
Revenue00-
Total Cash138M818M17%
Total Debt48.6M48.6M100%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLDDNLI
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
N/A
Bullish Trend 28 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AADEX27.260.18
+0.66%
American Beacon Large Cap Value R5
VWUSX73.45N/A
N/A
Vanguard US Growth Investor
MFLDX24.09N/A
N/A
Cromwell Long Short Institutional
DPWRX68.99N/A
N/A
BNY Mellon Worldwide Growth I
EVUDX19.97N/A
N/A
Allspring Util and Telecomms Adm

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with DSGN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then DSGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
+3.81%
DSGN - BOLD
35%
Loosely correlated
+0.78%
INBX - BOLD
33%
Loosely correlated
+0.34%
PRME - BOLD
33%
Poorly correlated
+2.74%
LYEL - BOLD
33%
Poorly correlated
+4.41%
ETXPF - BOLD
32%
Poorly correlated
N/A
More